{"id":"combination-bnt162b2-and-bnt162b2-omi","rwe":[],"tags":[],"safety":{"drugInteractions":[{"drug":"Warfarin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Aspirin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Pain medications (e.g., ibuprofen, naproxen)","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Anticoagulants (e.g., heparin, enoxaparin)","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Antiplatelets (e.g., clopidogrel, ticagrelor)","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Thrombolytics (e.g., alteplase, tenecteplase)","action":"Avoid","effect":"Increased risk of bleeding"},{"drug":"Live vaccines","action":"Avoid","effect":"Reduced efficacy of vaccine"},{"drug":"Interferons (e.g., interferon-alpha, interferon-beta)","action":"Avoid","effect":"Reduced efficacy of vaccine"},{"drug":"Immunosuppressants (e.g., corticosteroids, cyclosporine)","action":"Avoid","effect":"Reduced efficacy of vaccine"}],"commonSideEffects":[{"effect":"Injection site pain","drugRate":"13.2%","organSystem":"General disorders","placeboRate":"","totalAtRisk":5080,"totalAffected":673,"trialsReporting":1},{"effect":"Fatigue","drugRate":"7.5%","organSystem":"General disorders","placeboRate":"","totalAtRisk":5080,"totalAffected":383,"trialsReporting":1},{"effect":"Headache","drugRate":"5.3%","organSystem":"Nervous system disorders","placeboRate":"","totalAtRisk":5080,"totalAffected":267,"trialsReporting":1},{"effect":"Pyrexia","drugRate":"5.1%","organSystem":"General disorders","placeboRate":"","totalAtRisk":5080,"totalAffected":258,"trialsReporting":1},{"effect":"Myalgia","drugRate":"4.9%","organSystem":"Musculoskeletal and connective tissue disorders","placeboRate":"","totalAtRisk":5080,"totalAffected":248,"trialsReporting":1},{"effect":"Chills","drugRate":"4.8%","organSystem":"General disorders","placeboRate":"","totalAtRisk":5080,"totalAffected":243,"trialsReporting":1},{"effect":"Lymphadenopathy","drugRate":"2.8%","organSystem":"Blood and lymphatic system disorders","placeboRate":"","totalAtRisk":5080,"totalAffected":141,"trialsReporting":1},{"effect":"Pain","drugRate":"2.7%","organSystem":"General disorders","placeboRate":"","totalAtRisk":5080,"totalAffected":139,"trialsReporting":1},{"effect":"Pain in extremity","drugRate":"1.1%","organSystem":"Musculoskeletal and connective tissue disorders","placeboRate":"","totalAtRisk":5080,"totalAffected":58,"trialsReporting":1},{"effect":"Nausea","drugRate":"1.1%","organSystem":"Gastrointestinal disorders","placeboRate":"","totalAtRisk":5080,"totalAffected":54,"trialsReporting":1},{"effect":"Diarrhoea (DIARRHEA)","drugRate":"0.0%","organSystem":"Gastrointestinal disorders","placeboRate":"","totalAtRisk":5080,"totalAffected":0,"trialsReporting":1},{"effect":"Vomiting (VOMITING)","drugRate":"0.0%","organSystem":"Gastrointestinal disorders","placeboRate":"","totalAtRisk":5080,"totalAffected":0,"trialsReporting":1},{"effect":"Chills (CHILLS)","drugRate":"0.0%","organSystem":"General disorders","placeboRate":"","totalAtRisk":5080,"totalAffected":0,"trialsReporting":1},{"effect":"Fatigue (FATIGUE)","drugRate":"0.0%","organSystem":"General disorders","placeboRate":"","totalAtRisk":5080,"totalAffected":0,"trialsReporting":1},{"effect":"Injection site erythema (REDNESS)","drugRate":"0.0%","organSystem":"General disorders","placeboRate":"","totalAtRisk":5080,"totalAffected":0,"trialsReporting":1},{"effect":"Injection site pain (PAIN)","drugRate":"0.0%","organSystem":"General disorders","placeboRate":"","totalAtRisk":5080,"totalAffected":0,"trialsReporting":1},{"effect":"Injection site swelling (SWELLING)","drugRate":"0.0%","organSystem":"General disorders","placeboRate":"","totalAtRisk":5080,"totalAffected":0,"trialsReporting":1},{"effect":"Pyrexia (FEVER)","drugRate":"0.0%","organSystem":"General disorders","placeboRate":"","totalAtRisk":5080,"totalAffected":0,"trialsReporting":1},{"effect":"SARS-CoV-2 test positive","drugRate":"0.0%","organSystem":"Investigations","placeboRate":"","totalAtRisk":5080,"totalAffected":0,"trialsReporting":1},{"effect":"Arthralgia (JOINT PAIN)","drugRate":"0.0%","organSystem":"Musculoskeletal and connective tissue disorders","placeboRate":"","totalAtRisk":5080,"totalAffected":0,"trialsReporting":1},{"effect":"Myalgia (MUSCLE PAIN)","drugRate":"0.0%","organSystem":"Musculoskeletal and connective tissue disorders","placeboRate":"","totalAtRisk":5080,"totalAffected":0,"trialsReporting":1},{"effect":"Headache (HEADACHE)","drugRate":"0.0%","organSystem":"Nervous system disorders","placeboRate":"","totalAtRisk":5080,"totalAffected":0,"trialsReporting":1},{"effect":"Eye pruritis","drugRate":"0.0%","organSystem":"Eye disorders","placeboRate":"","totalAtRisk":5080,"totalAffected":0,"trialsReporting":1},{"effect":"Abdominal pain","drugRate":"0.0%","organSystem":"Gastrointestinal disorders","placeboRate":"","totalAtRisk":5080,"totalAffected":0,"trialsReporting":1},{"effect":"Syncope","drugRate":"0.0%","organSystem":"Nervous system disorders","placeboRate":"","totalAtRisk":5080,"totalAffected":0,"trialsReporting":1},{"effect":"Seasonal allergy","drugRate":"0.0%","organSystem":"Immune system disorders","placeboRate":"","totalAtRisk":5080,"totalAffected":0,"trialsReporting":1},{"effect":"Ear infections","drugRate":"0.0%","organSystem":"Infections and infestations","placeboRate":"","totalAtRisk":5080,"totalAffected":0,"trialsReporting":1},{"effect":"Arthralgia","drugRate":"0.0%","organSystem":"Musculoskeletal and connective tissue disorders","placeboRate":"","totalAtRisk":5080,"totalAffected":0,"trialsReporting":1},{"effect":"Attention deficit-hyperactivity disorder","drugRate":"0.0%","organSystem":"Psychiatric disorders","placeboRate":"","totalAtRisk":5080,"totalAffected":0,"trialsReporting":1},{"effect":"Dysmenorrhoea","drugRate":"0.0%","organSystem":"Reproductive system and breast disorders","placeboRate":"","totalAtRisk":5080,"totalAffected":0,"trialsReporting":1},{"effect":"Epistaxis","drugRate":"0.0%","organSystem":"Respiratory, thoracic and mediastinal disorders","placeboRate":"","totalAtRisk":5080,"totalAffected":0,"trialsReporting":1},{"effect":"Rhinitis allergic","drugRate":"0.0%","organSystem":"Respiratory, thoracic and mediastinal disorders","placeboRate":"","totalAtRisk":5080,"totalAffected":0,"trialsReporting":1},{"effect":"Injection site swelling","drugRate":"0.0%","organSystem":"General disorders","placeboRate":"","totalAtRisk":5080,"totalAffected":0,"trialsReporting":1},{"effect":"Dry mouth","drugRate":"0.0%","organSystem":"Gastrointestinal disorders","placeboRate":"","totalAtRisk":5080,"totalAffected":0,"trialsReporting":1},{"effect":"Axillary pain","drugRate":"0.0%","organSystem":"General disorders","placeboRate":"","totalAtRisk":5080,"totalAffected":0,"trialsReporting":1},{"effect":"Swelling","drugRate":"0.0%","organSystem":"General disorders","placeboRate":"","totalAtRisk":5080,"totalAffected":0,"trialsReporting":1},{"effect":"Corneal abrasion","drugRate":"0.0%","organSystem":"Injury, poisoning and procedural complications","placeboRate":"","totalAtRisk":5080,"totalAffected":0,"trialsReporting":1},{"effect":"Gout","drugRate":"0.0%","organSystem":"Metabolism and nutrition disorders","placeboRate":"","totalAtRisk":5080,"totalAffected":0,"trialsReporting":1},{"effect":"Bone swelling","drugRate":"0.0%","organSystem":"Musculoskeletal and connective tissue disorders","placeboRate":"","totalAtRisk":5080,"totalAffected":0,"trialsReporting":1},{"effect":"Disturbance in attention","drugRate":"0.0%","organSystem":"Nervous system disorders","placeboRate":"","totalAtRisk":5080,"totalAffected":0,"trialsReporting":1},{"effect":"Abnormal dreams","drugRate":"0.0%","organSystem":"Psychiatric disorders","placeboRate":"","totalAtRisk":5080,"totalAffected":0,"trialsReporting":1},{"effect":"Anxiety","drugRate":"0.0%","organSystem":"Psychiatric disorders","placeboRate":"","totalAtRisk":5080,"totalAffected":0,"trialsReporting":1},{"effect":"Panic disorder","drugRate":"0.0%","organSystem":"Psychiatric disorders","placeboRate":"","totalAtRisk":5080,"totalAffected":0,"trialsReporting":1},{"effect":"Dry throat","drugRate":"0.0%","organSystem":"Respiratory, thoracic and mediastinal disorders","placeboRate":"","totalAtRisk":5080,"totalAffected":0,"trialsReporting":1},{"effect":"Pruritus","drugRate":"0.0%","organSystem":"Skin and subcutaneous tissue disorders","placeboRate":"","totalAtRisk":5080,"totalAffected":0,"trialsReporting":1},{"effect":"Haematochezia","drugRate":"0.0%","organSystem":"Gastrointestinal disorders","placeboRate":"","totalAtRisk":5080,"totalAffected":0,"trialsReporting":1},{"effect":"Feeling abnormal","drugRate":"0.0%","organSystem":"General disorders","placeboRate":"","totalAtRisk":5080,"totalAffected":0,"trialsReporting":1},{"effect":"Onychomycosis","drugRate":"0.0%","organSystem":"Infections and infestations","placeboRate":"","totalAtRisk":5080,"totalAffected":0,"trialsReporting":1},{"effect":"Sinusitis","drugRate":"0.0%","organSystem":"Infections and infestations","placeboRate":"","totalAtRisk":5080,"totalAffected":0,"trialsReporting":1},{"effect":"Skin infection","drugRate":"0.0%","organSystem":"Infections and infestations","placeboRate":"","totalAtRisk":5080,"totalAffected":0,"trialsReporting":1}],"contraindications":["Do not administer COMIRNATY to individuals with known history of a severe allergic reaction (e.g., anaphylaxis) to any component of COMIRNATY [see Description (11)] or to individuals who had a severe allergic reaction (e.g., anaphylaxis) following a previous dose of a Pfizer-BioNTech COVID-19 vaccine."],"specialPopulations":{"Pregnancy":"Pregnant Women: The safety and efficacy of COMIRNATY Original & Omicron BA.4/BA.5 in pregnant women have not been established. The potential benefits and risks of the vaccine in pregnant women have not been adequately assessed. If a decision is made to administer COMIRNATY Original & Omicron BA.4/BA.5 to a pregnant woman, the potential benefits and risks of the vaccine should be carefully considered.","Geriatric use":"Geriatrics: No specific information is available on the use of COMIRNATY Original & Omicron BA.4/BA.5 in geriatric patients. However, elderly individuals may be more susceptible to the effects of vaccination due to decreased immune function and age-related comorbidities.","Paediatric use":"For Age 6 Months to <5 Years: Maroon Cap - DILUTE PRIOR TO USE (after dilution each multiple dose vial should be used within 6 hours if stored at 2°C to 8°C or within 24 hours if stored at -20°C).","Renal impairment":"No information is available on the use of COMIRNATY Original & Omicron BA.4/BA.5 in patients with renal impairment.","Hepatic impairment":"No information is available on the use of COMIRNATY Original & Omicron BA.4/BA.5 in patients with hepatic impairment."},"seriousAdverseEvents":[{"event":"Acute myocardial infarction","detail":"Cardiac disorders. 1 trial(s).","severity":"serious","incidence":"0.1%"},{"event":"Atrial fibrillation","detail":"Cardiac disorders. 1 trial(s).","severity":"serious","incidence":"0.1%"},{"event":"Appendicitis","detail":"Infections and infestations. 1 trial(s).","severity":"serious","incidence":"0.1%"},{"event":"Prostate cancer","detail":"Neoplasms benign, malignant and unspecified (incl cysts and polyps). 1 trial(s).","severity":"serious","incidence":"0.1%"},{"event":"Syncope","detail":"Nervous system disorders. 1 trial(s).","severity":"serious","incidence":"0.1%"},{"event":"Nephrolithiasis","detail":"Renal and urinary disorders. 1 trial(s).","severity":"serious","incidence":"0.1%"},{"event":"Sickle cell anaemia with crisis","detail":"Blood and lymphatic system disorders. 1 trial(s).","severity":"serious","incidence":"0.0%"},{"event":"Cardiac failure","detail":"Cardiac disorders. 1 trial(s).","severity":"serious","incidence":"0.0%"},{"event":"Coronary artery disease","detail":"Cardiac disorders. 1 trial(s).","severity":"serious","incidence":"0.0%"},{"event":"Myocardial infarction","detail":"Cardiac disorders. 1 trial(s).","severity":"serious","incidence":"0.0%"},{"event":"Myopericarditis","detail":"Cardiac disorders. 1 trial(s).","severity":"serious","incidence":"0.0%"},{"event":"Coronary artery insufficiency","detail":"Cardiac disorders. 1 trial(s).","severity":"serious","incidence":"0.0%"},{"event":"Pericarditis","detail":"Cardiac disorders. 1 trial(s).","severity":"serious","incidence":"0.0%"},{"event":"Tachycardia","detail":"Cardiac disorders. 1 trial(s).","severity":"serious","incidence":"0.0%"},{"event":"Ventricular extrasystoles","detail":"Cardiac disorders. 1 trial(s).","severity":"serious","incidence":"0.0%"},{"event":"Goitre","detail":"Endocrine disorders. 1 trial(s).","severity":"serious","incidence":"0.0%"},{"event":"Colitis","detail":"Gastrointestinal disorders. 1 trial(s).","severity":"serious","incidence":"0.0%"},{"event":"Gastric fistula","detail":"Gastrointestinal disorders. 1 trial(s).","severity":"serious","incidence":"0.0%"},{"event":"Gastrointestinal haemorrhage","detail":"Gastrointestinal disorders. 1 trial(s).","severity":"serious","incidence":"0.0%"},{"event":"Hiatus hernia","detail":"Gastrointestinal disorders. 1 trial(s).","severity":"serious","incidence":"0.0%"},{"event":"Intestinal perforation","detail":"Gastrointestinal disorders. 1 trial(s).","severity":"serious","incidence":"0.0%"},{"event":"Lower gastrointestinal haemorrhage","detail":"Gastrointestinal disorders. 1 trial(s).","severity":"serious","incidence":"0.0%"},{"event":"Pancreatitis acute","detail":"Gastrointestinal disorders. 1 trial(s).","severity":"serious","incidence":"0.0%"},{"event":"Small intestinal obstruction","detail":"Gastrointestinal disorders. 1 trial(s).","severity":"serious","incidence":"0.0%"},{"event":"Upper gastrointestinal haemorrhage","detail":"Gastrointestinal disorders. 1 trial(s).","severity":"serious","incidence":"0.0%"},{"event":"Chest pain","detail":"General disorders. 1 trial(s).","severity":"serious","incidence":"0.0%"},{"event":"Death","detail":"General disorders. 1 trial(s).","severity":"serious","incidence":"0.0%"},{"event":"Non-cardiac chest pain","detail":"General disorders. 1 trial(s).","severity":"serious","incidence":"0.0%"},{"event":"Sudden cardiac death","detail":"General disorders. 1 trial(s).","severity":"serious","incidence":"0.0%"},{"event":"Bile duct stone","detail":"Hepatobiliary disorders. 1 trial(s).","severity":"serious","incidence":"0.0%"}]},"trials":[],"aliases":[],"company":"Pfizer","patents":[],"pricing":[],"_sources":{"patents":{"url":"","method":"deterministic","source":"FDA Orange Book + Purple Book","rawText":"","confidence":1,"sourceType":"fda_orange_book","retrievedAt":"2026-04-19T23:10:26.411905+00:00"},"aiSummary":{"url":"","method":"ai_extraction","source":"AI Strategic Summary","aiModel":"featherless","rawText":"","confidence":0.9,"sourceType":"ai_extraction","retrievedAt":"2026-04-19T23:10:35.047562+00:00"},"chemblData":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4650429/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-19T23:10:19.999668+00:00"},"trialDetails":{"url":"","method":"deterministic","source":"ClinicalTrials.gov (1 trials with endpoints)","rawText":"","confidence":1,"sourceType":"ctgov_results","retrievedAt":"2026-04-19T23:10:36.563070+00:00"},"publicationCount":{"url":"","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-19T23:10:18.582267+00:00"},"participantFlowData":{"url":"","method":"deterministic","source":"ClinicalTrials.gov participantFlowModule","rawText":"","confidence":1,"sourceType":"ctgov_results","retrievedAt":"2026-04-19T23:10:36.563061+00:00"},"structuredTrialResults":{"url":"","method":"deterministic","source":"ClinicalTrials.gov resultsSection (1 trials)","rawText":"","confidence":1,"sourceType":"ctgov_results","retrievedAt":"2026-04-19T23:10:36.563050+00:00"},"safety.commonSideEffects":{"url":"","method":"deterministic","source":"ClinicalTrials.gov (1 trials)","rawText":"","confidence":1,"sourceType":"ctgov_results","retrievedAt":"2026-04-20T08:33:34.912730+00:00"},"safety.seriousAdverseEvents":{"url":"","method":"deterministic","source":"ClinicalTrials.gov (1 trials)","rawText":"","confidence":1,"sourceType":"ctgov_results","retrievedAt":"2026-04-19T23:10:36.559976+00:00"}},"allNames":"combination bnt162b2 and bnt162b2 omi","offLabel":[],"timeline":[],"aiSummary":"Combination BNT162b2 and BNT162b2 OMI, developed by Pfizer, holds a significant market position as one of the leading mRNA-based vaccines for preventing and treating COVID-19. Its competitive advantage lies in its dual-action mechanism, which may offer broader protection compared to monovalent vaccines. However, a key risk is the intense competition from BioNTech’s BNT162b5 and bivalent formulations, all of which are currently in Phase 2/3 clinical trials. The pipeline outlook remains robust, with ongoing evaluations and potential for additional indications, though the requirement for a PD-L1 companion diagnostic for some uses may limit its applicability.","brandName":"Combination BNT162b2 and BNT162b2 OMI","ecosystem":[],"isGeneric":true,"mechanism":{"target":"SARS-CoV-2 spike protein","novelty":"best-in-class","modality":"mRNA-based vaccine","drugClass":"mRNA vaccine","explanation":"Pfizer's combination BNT162b2 and BNT162b2 OMI is a unique approach to COVID-19 prevention and treatment. This combination of two mRNA-based vaccines works by instructing cells to produce a specific protein that triggers an immune response. This immune response helps to prevent and treat COVID-19. The combination of these two vaccines may provide a more effective and longer-lasting protection against COVID-19 compared to a single vaccine.","oneSentence":"A combination of two mRNA-based vaccines that work together to prevent and treat COVID-19.","technicalDetail":"The combination of BNT162b2 and BNT162b2 OMI works by encoding the SARS-CoV-2 spike protein in the mRNA, which is then translated into the protein by the host cells. This protein is recognized by the immune system, triggering an immune response that helps to prevent and treat COVID-19. The combination of these two vaccines may also provide a synergistic effect, enhancing the immune response and providing longer-lasting protection."},"_companyIR":{"url":"https://www.pfizer.com/investors","revenueRefs":[],"pipelineRefs":[]},"chemblData":{"prodrug":0,"chemblId":"CHEMBL4650429","maxPhase":"4.0","chirality":1,"parenteral":false,"availability":-1,"moleculeType":"Vaccine component","withdrawnFlag":false,"naturalProduct":0,"blackBoxWarning":0,"oralBioavailable":false},"commercial":{"yoyGrowth":"+7%","annualCostUS":"$80,000/yr","genericStatus":"Generic — off-patent","currentRevenue":"$21.2B","patientPopulation":"","peakSalesEstimate":"$21.2B"},"fdaRecalls":[],"references":[{"id":1,"url":"https://clinicaltrials.gov/search?intr=combination-bnt162b2-and-bnt162b2-omi","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=combination-bnt162b2-and-bnt162b2-omi","fields":["publications"],"source":"PubMed/NCBI"},{"id":3,"url":"https://www.ebi.ac.uk/chembl/","fields":["molecular"],"source":"ChEMBL (EMBL-EBI)"},{"id":4,"url":"https://www.ema.europa.eu/","fields":["regulatoryStatus"],"source":"European Medicines Agency (EMA)"},{"id":5,"url":"https://list.essentialmeds.org/","fields":["regulatoryStatus"],"source":"WHO Essential Medicines List"}],"_tgaChecked":true,"_validation":{"fieldsValidated":4,"lastValidatedAt":"2026-04-20T08:33:42.246013+00:00","fieldsConflicting":0,"overallConfidence":0.95},"_whoChecked":true,"biosimilars":[],"competitors":[{"name":"BNT162b5","company":"BioNTech","advantage":"Has demonstrated a high level of protection against several variants of concern"},{"name":"BNT162b5 Bivalent (Original/OMI BA.4/BA.5)","company":"BioNTech","advantage":"Competes with BNT162b2 Bivalent (Original/ OMI BA.4/BA.5) in a Phase 2/3 clinical trial"},{"name":"BNT162b6 Bivalent (Original/OMI BA.4/BA.5)","company":"BioNTech","advantage":"Competes with BNT162b2 Bivalent (Original/ OMI BA.4/BA.5) in a Phase 2/3 clinical trial"},{"name":"BNT162b7 Bivalent (Original/OMI BA.4/BA.5)","company":"BioNTech","advantage":"Competes with BNT162b2 Bivalent (Original/ OMI BA.4/BA.5) in a Phase 2/3 clinical trial"},{"name":"BNT162b7 Monovalent (OMI BA.4/BA.5)","company":"BioNTech","advantage":"Competes with BNT162b2 Bivalent (Original/ OMI BA.4/BA.5) in a Phase 2/3 clinical trial"},{"name":"BNT162b5","company":"BioNTech","advantage":"Has demonstrated a high level of protection against several variants of concern"},{"name":"BNT162b2 Bivalent (Original/ OMI BA.4/BA.5)","company":"BioNTech","advantage":"Competes with BNT162b5 Bivalent (Original/OMI BA.4/BA.5) in a Phase 2/3 clinical trial"},{"name":"BNT162b2 Bivalent (WT/OMI BA.1)","company":"BioNTech","advantage":"Competes with BNT162b5 Bivalent (WT/OMI BA.2) in a Phase 2/3 clinical trial"},{"name":"BNT162b2 Bivalent (WT/OMI BA.4/BA.5)","company":"BioNTech","advantage":"Competes with BNT162b5 Bivalent (WT/OMI BA.2) in a Phase 2/3 clinical trial"},{"name":"BNT162b2","company":"BioNTech","advantage":"Has demonstrated a high level of protection against several variants of concern"},{"name":"BNT162b2 OMI (combination-bnt162b2-and-bnt162b2-omi)","company":"BioNTech","advantage":"Competes with BNT162b5 Bivalent (WT/OMI BA.2) in a Phase 2/3 clinical trial"},{"name":"BNT116","company":"BioNTech","advantage":"Being evaluated in a Phase 1 clinical trial"},{"name":"Pfizer’s BNT162b5","company":"Pfizer","advantage":"Launched a Phase II study to test efficacy in their new and improved candidate"}],"genericName":"combination-bnt162b2-and-bnt162b2-omi","indications":{"approved":[{"name":"COVID-19 prevention","regulator":"FDA"},{"name":"COVID-19 treatment","regulator":"FDA"}],"offLabel":[],"pipeline":[]},"_mhraChecked":true,"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT04955626","phase":"PHASE3","title":"To Evaluate the Safety, Tolerability, Efficacy and Immunogenicity of BNT162b2 Boosting Strategies Against COVID-19 in Participants ≥12 Years of Age.","status":"","acronym":null,"sponsor":"BioNTech SE","isPivotal":false,"primaryCI":"[89.5, 98.3]","primaryHR":"95.3","enrollment":16372,"indication":"SARS-CoV-2 Infection, COVID-19","endpointCount":111,"primaryPValue":"","completionDate":"","primaryEndpoint":"SSA: Occurrence of First COVID-19 Infection After Booster Dose Per 1000 Person-Years of Blinded Follow-up Without Evidence of Past SARS-CoV-2 Infection at Interim Analysis: Evaluable Efficacy Population"}],"_emaApprovals":[{"date":"","name":"Combination BNT162b2 and BNT162b2 OMI","status":"Authorised","regulator":"EMA"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"molecularData":{"oral":false,"chemblId":"CHEMBL4650429","moleculeType":"Vaccine component","molecularWeight":""},"_patentsChecked":true,"_warningLetters":[{"date":"03/28/2023","subject":"11/07/2022\tTodos Medical Ltd aka Todos Medical USA Inc\tCenter for Food Safety and Applied Nutrition"},{"date":"03/27/2026","subject":"Feedback form"}],"crossReferences":{"chemblId":"CHEMBL4650429"},"formularyStatus":[],"_offLabelChecked":true,"chemblMechanisms":[{"actionType":"VACCINE ANTIGEN","targetChemblId":"CHEMBL4662936","mechanismComment":null,"mechanismOfAction":"Spike glycoprotein vaccine antigen"}],"developmentCodes":[],"ownershipHistory":[],"publicationCount":0,"therapeuticAreas":["Infectious Disease"],"biosimilarFilings":[],"recentPublications":[],"_drugWebsiteChecked":true,"participantFlowData":[{"nctId":"NCT04955626","groups":[{"id":"FG000","title":"SSA: BNT162b2 30 mcg: Blinded and Open Label Period","description":"Participants received one dose (30 microgram) of BNT162b2 intramuscularly in the deltoid muscle of the non-dominant arm."},{"id":"FG001","title":"SSA: Placebo: Blinded Period, Then BNT162b2 30 mcg Open-Label Period","description":"Participants received placebo (normal saline solution of 0.9 percent \\[%\\] sodium chloride) intramuscularly during the Double-Blinded period. Then, they could have received BNT162b2 30 mcg in the Open"},{"id":"FG002","title":"SSB: BNT162b2 30 mcg Then Placebo","description":"Participants received one dose (30 mcg) of BNT162b2 intramuscularly in the deltoid muscle of the non-dominant arm on Day 1 and received placebo (normal saline solution of 0.9 % sodium chloride) intram"},{"id":"FG003","title":"SSB: Placebo Then BNT162b2 30 mcg","description":"Participants received placebo (normal saline solution of 0.9 % sodium chloride) intramuscularly on Day 1 and one dose (30 mcg) of BNT162b2 intramuscularly in the deltoid muscle of the non-dominant arm"},{"id":"FG004","title":"SSC: BNT162b2 10 mcg","description":"Participants who previously received two booster doses of BNT162b2 prior to enrollment in SSC, received one booster dose (10 mcg) of BNT162b2 intramuscularly in the deltoid muscle of the non-dominant "},{"id":"FG005","title":"SSC: BNT162b2 30 mcg","description":"Participants who previously received two booster doses of BNT162b2 prior to enrollment in SSC, received one booster dose (30 mcg) of BNT162b2 intramuscularly in the deltoid muscle of the non-dominant "},{"id":"FG006","title":"SSD: Cohort 1: Group 1","description":"Participants received one dose (30 mcg) of BNT162b2 Omicron (OMI) intramuscularly in the deltoid muscle of the non-dominant arm."},{"id":"FG007","title":"SSD: Cohort 1: Group 2","description":"Participants received two doses (30 mcg) of BNT162b2 Omicron (OMI) intramuscularly 4 weeks apart in the deltoid muscle of the non-dominant arm."},{"id":"FG008","title":"SSD: Cohort 1: Group 2b","description":"Participants received one dose (30 mcg) of BNT162b2 intramuscularly in the deltoid muscle of the non-dominant arm."},{"id":"FG009","title":"SSD: Cohort 2: Group 3","description":"Participants received one dose (30 mcg) of BNT162b2 Omicron (OMI) intramuscularly in the deltoid muscle of the non-dominant arm. After 3 months, participants upon their consent received optional addit"},{"id":"FG010","title":"SSD: Cohort 2: Group 4","description":"Participants received one dose (30 mcg) of BNT162b2 intramuscularly in the deltoid muscle of the non-dominant arm. After 3 months, participants upon their consent received optional additional one dose"},{"id":"FG011","title":"SSD: Cohort 3: Group 5","description":"Participants received two doses (30 mcg) of BNT162b2 Omicron (OMI) 3 weeks apart intramuscularly in the deltoid muscle of the non-dominant arm. Participants upon their consent received one dose (30 mc"},{"id":"FG012","title":"SSE: Sentinel Cohort (18-55 Years): BNT 30mcg + BNT OMI 30 mcg","description":"Participants received a total of 60 mcg bivalent BNT162b2 (30 mcg BNT162b2 and 30 mcg BNT162b2 OMI) as a single dose intramuscularly in the deltoid muscle of the non-dominant arm."},{"id":"FG013","title":"SSE: Sentinel Cohort (18-55 Years): BNT 15 mcg +BNT OMI 15 mcg","description":"Participants received a total of 30 mcg bivalent BNT162b2 (15 mcg BNT162b2 and 15 mcg BNT162b2 OMI) as a single dose intramuscularly in the deltoid muscle of the non-dominant arm."},{"id":"FG014","title":"SSE: Sentinel Cohort (18 to 55 Years): BNT162b2 OMI 60 mcg","description":"Participants received one dose (60 mcg) of BNT162b2 OMI intramuscularly in the deltoid muscle of the non-dominant arm."},{"id":"FG015","title":"SSE: Expanded Cohort (18-55 Years): BNT 30 mcg +BNT OMI 30 mcg","description":"Participants received a total of 60 mcg bivalent BNT162b2 (30 mcg BNT162b2 and 30 mcg BNT162b2 OMI) as a single dose intramuscularly in the deltoid muscle of the non-dominant arm."},{"id":"FG016","title":"SSE: Expanded Cohort (18-55 Years): BNT 15 mcg +BNT OMI 15 mcg","description":"Participants received a total of 30 mcg bivalent BNT162b2 (15 mcg BNT162b2 and 15 mcg BNT162b2 OMI) as a single dose intramuscularly in the deltoid muscle of the non-dominant arm."},{"id":"FG017","title":"SSE: Expanded Cohort (18 to 55 Years): BNT162b2 OMI 60 mcg","description":"Participants received one dose (60 mcg) of BNT162b2 Omicron (OMI) intramuscularly in the deltoid muscle of the non-dominant arm."},{"id":"FG018","title":"SSE: Sentinel Cohort (> 55 Years): BNT162b2 30 mcg","description":"Participants received one dose (30 mcg) of BNT162b2 intramuscularly in the deltoid muscle of the non-dominant arm."},{"id":"FG019","title":"SSE: Sentinel Cohort (> 55 Years): BNT162b2 60 mcg","description":"Participants received one dose (60 mcg) of BNT162b2 intramuscularly in the deltoid muscle of the non-dominant arm."},{"id":"FG020","title":"SSE: Sentinel Cohort (> 55 Years): BNT162b2 OMI 30 mcg","description":"Participants received one dose (30 mcg) of BNT162b2 OMI intramuscularly in the deltoid muscle of the non-dominant arm."},{"id":"FG021","title":"SSE: Sentinel Cohort (> 55 Years): BNT162b2 OMI 60 mcg","description":"Participants received one dose (60 mcg) of BNT162b2 Omicron (OMI) intramuscularly in the deltoid muscle of the non-dominant arm."},{"id":"FG022","title":"SSE: Sentinel Cohort (> 55 Years): BNT 15 mcg + BNT OMI 15 mcg","description":"Participants received a total of 30 mcg bivalent BNT162b2 (15 mcg BNT162b2 and 15 mcg BNT162b2 OMI) as a single dose intramuscularly in the deltoid muscle of the non-dominant arm."},{"id":"FG023","title":"SSE: Sentinel Cohort (> 55 Years): BNT 30 mcg +BNT OMI 30 mcg","description":"Participants received a total of 60 mcg bivalent BNT162b2 (30 mcg BNT162b2 and 30 mcg BNT162b2 OMI) as a single dose intramuscularly in the deltoid muscle of the non-dominant arm."},{"id":"FG024","title":"SSE: Expanded Cohort (> 55 Years): BNT162b2 30 mcg","description":"Participants received one dose (30 mcg) of BNT162b2 intramuscularly in the deltoid muscle of the non-dominant arm."},{"id":"FG025","title":"SSE: Expanded Cohort (> 55 Years): BNT162b2 60 mcg","description":"Participants received one dose (60 mcg) of BNT162b2 intramuscularly in the deltoid muscle of the non-dominant arm."},{"id":"FG026","title":"SSE: Expanded Cohort (> 55 Years): BNT162b2 OMI 30 mcg","description":"Participants received one dose (30 mcg) of BNT162b2 OMI intramuscularly in the deltoid muscle of the non-dominant arm."},{"id":"FG027","title":"SSE: Expanded Cohort (> 55 Years): BNT162b2 OMI 60 mcg","description":"Participants received one dose (60 mcg) of BNT162b2 Omicron (OMI) intramuscularly in the deltoid muscle of the non-dominant arm."},{"id":"FG028","title":"SSE: Expanded Cohort (> 55 Years): BNT 15 mcg + BNT OMI 15 mcg","description":"Participants received a total of 30 mcg bivalent BNT162b2 (15 mcg BNT162b2 and 15 mcg BNT162b2 OMI) as a single dose intramuscularly in the deltoid muscle of the non-dominant arm."},{"id":"FG029","title":"SSE: Expanded Cohort (> 55 Years): BNT 30 mcg +BNT OMI 30 mcg","description":"Participants received a total of 60 mcg bivalent BNT162b2 (30 mcg BNT162b2 and 30 mcg BNT162b2 OMI) as a single dose intramuscularly in the deltoid muscle of the non-dominant arm."},{"id":"FG030","title":"SSF: BNT162b2 30 mcg","description":"Participants received one dose (30 mcg) of BNT162b2 intramuscularly in the deltoid muscle of the non-dominant arm."},{"id":"FG031","title":"SSF: BNT162b2 60 mcg","description":"Participants received one dose (60 mcg) of BNT162b2 intramuscularly in the deltoid muscle of the non-dominant arm."},{"id":"FG032","title":"SSF: BNT162b2 OMI 30 mcg","description":"Participants received one dose (30 mcg) of BNT162b2 Omicron (OMI) intramuscularly in the deltoid muscle of the non-dominant arm."},{"id":"FG033","title":"SSF: BNT162b2 OMI 60 mcg","description":"Participants received one dose (60 mcg) of BNT162b2 Omicron (OMI) intramuscularly in the deltoid muscle of the non-dominant arm."},{"id":"FG034","title":"SSF: BNT162b2 15 mcg + BNT162b2 OMI 15 mcg","description":"Participants received a total of 30 mcg bivalent BNT162b2 (15 mcg BNT162b2 and 15 mcg BNT162b2 OMI) as a single dose intramuscularly in the deltoid muscle of the non-dominant arm."},{"id":"FG035","title":"SSF: BNT162b2 30 mcg + BNT162b2 OMI 30 mcg","description":"Participants received a total of 60 mcg bivalent BNT162b2 (30 mcg BNT162b2 and 30 mcg BNT162b2 OMI) as a single dose intramuscularly in the deltoid muscle of the non-dominant arm."}],"acronym":null,"periods":[{"title":"Blinded Period","milestones":[{"type":"STARTED","counts":{"FG000":"5080","FG001":"5041","FG002":"753","FG003":"732","FG004":"75","FG005":"65","FG006":"216","FG007":"197","FG008":"204","FG009":"315","FG010":"325","FG011":"210","FG012":"30","FG013":"30","FG014":"30","FG015":"482","FG016":"159","FG017":"321","FG018":"20","FG019":"20","FG020":"20","FG021":"20","FG022":"20","FG023":"20","FG024":"305","FG025":"302","FG026":"307","FG027":"307","FG028":"308","FG029":"313","FG030":"21","FG031":"19","FG032":"21","FG033":"20","FG034":"20","FG035":"21"}},{"type":"Safety Analysis Set","counts":{"FG000":"5080","FG001":"5041","FG002":"753","FG003":"732","FG004":"75","FG005":"65","FG006":"216","FG007":"197","FG008":"204","FG009":"315","FG010":"323","FG011":"210","FG012":"30","FG013":"30","FG014":"30","FG015":"482","FG016":"159","FG017":"321","FG018":"20","FG019":"20","FG020":"20","FG021":"20","FG022":"20","FG023":"20","FG024":"305","FG025":"302","FG026":"307","FG027":"307","FG028":"308","FG029":"313","FG030":"21","FG031":"19","FG032":"21","FG033":"20","FG034":"20","FG035":"21"}},{"type":"COMPLETED","counts":{"FG000":"421","FG001":"22","FG002":"726","FG003":"693","FG004":"69","FG005":"58","FG006":"197","FG007":"183","FG008":"193","FG009":"286","FG010":"293","FG011":"159","FG012":"28","FG013":"30","FG014":"27","FG015":"450","FG016":"151","FG017":"302","FG018":"19","FG019":"19","FG020":"19","FG021":"19","FG022":"20","FG023":"19","FG024":"292","FG025":"294","FG026":"291","FG027":"299","FG028":"294","FG029":"307","FG030":"21","FG031":"19","FG032":"21","FG033":"20","FG034":"20","FG035":"21"}},{"type":"NOT COMPLETED","counts":{"FG000":"4659","FG001":"5019","FG002":"27","FG003":"39","FG004":"6","FG005":"7","FG006":"19","FG007":"14","FG008":"11","FG009":"29","FG010":"32","FG011":"51","FG012":"2","FG013":"0","FG014":"3","FG015":"32","FG016":"8","FG017":"19","FG018":"1","FG019":"1","FG020":"1","FG021":"1","FG022":"0","FG023":"1","FG024":"13","FG025":"8","FG026":"16","FG027":"8","FG028":"14","FG029":"6","FG030":"0","FG031":"0","FG032":"0","FG033":"0","FG034":"0","FG035":"0"}}],"dropWithdraws":[{"type":"Lost to Follow-up","counts":{"FG000":"28","FG001":"28","FG002":"7","FG003":"14","FG004":"3","FG005":"2","FG006":"6","FG007":"4","FG008":"5","FG009":"8","FG010":"10","FG011":"32","FG012":"0","FG013":"0","FG014":"0","FG015":"12","FG016":"2","FG017":"5","FG018":"0","FG019":"0","FG020":"0","FG021":"0","FG022":"0","FG023":"0","FG024":"3","FG025":"1","FG026":"2","FG027":"2","FG028":"2","FG029":"0","FG030":"0","FG031":"0","FG032":"0","FG033":"0","FG034":"0","FG035":"0"}},{"type":"Protocol Violation","counts":{"FG000":"5","FG001":"14","FG002":"0","FG003":"1","FG004":"2","FG005":"2","FG006":"0","FG007":"0","FG008":"0","FG009":"4","FG010":"6","FG011":"1","FG012":"0","FG013":"0","FG014":"2","FG015":"6","FG016":"4","FG017":"6","FG018":"0","FG019":"1","FG020":"0","FG021":"1","FG022":"0","FG023":"0","FG024":"4","FG025":"6","FG026":"5","FG027":"3","FG028":"4","FG029":"3","FG030":"0","FG031":"0","FG032":"0","FG033":"0","FG034":"0","FG035":"0"}},{"type":"Death","counts":{"FG000":"0","FG001":"2","FG002":"0","FG003":"0","FG004":"0","FG005":"0","FG006":"0","FG007":"2","FG008":"1","FG009":"1","FG010":"0","FG011":"2","FG012":"0","FG013":"0","FG014":"0","FG015":"0","FG016":"0","FG017":"0","FG018":"0","FG019":"0","FG020":"0","FG021":"0","FG022":"0","FG023":"1","FG024":"0","FG025":"0","FG026":"1","FG027":"1","FG028":"0","FG029":"1","FG030":"0","FG031":"0","FG032":"0","FG033":"0","FG034":"0","FG035":"0"}},{"type":"Adverse Event","counts":{"FG000":"0","FG001":"1","FG002":"1","FG003":"1","FG004":"0","FG005":"0","FG006":"0","FG007":"0","FG008":"0","FG009":"1","FG010":"1","FG011":"0","FG012":"0","FG013":"0","FG014":"0","FG015":"0","FG016":"0","FG017":"0","FG018":"1","FG019":"0","FG020":"0","FG021":"0","FG022":"0","FG023":"0","FG024":"0","FG025":"0","FG026":"1","FG027":"0","FG028":"0","FG029":"0","FG030":"0","FG031":"0","FG032":"0","FG033":"0","FG034":"0","FG035":"0"}},{"type":"No longer meets eligibility criteria","counts":{"FG000":"1","FG001":"2","FG002":"0","FG003":"1","FG004":"0","FG005":"0","FG006":"0","FG007":"0","FG008":"1","FG009":"0","FG010":"1","FG011":"1","FG012":"0","FG013":"0","FG014":"0","FG015":"3","FG016":"0","FG017":"2","FG018":"0","FG019":"0","FG020":"0","FG021":"0","FG022":"0","FG023":"0","FG024":"1","FG025":"0","FG026":"0","FG027":"1","FG028":"0","FG029":"0","FG030":"0","FG031":"0","FG032":"0","FG033":"0","FG034":"0","FG035":"0"}},{"type":"Other","counts":{"FG000":"54","FG001":"3","FG002":"4","FG003":"2","FG004":"0","FG005":"0","FG006":"2","FG007":"2","FG008":"1","FG009":"0","FG010":"1","FG011":"1","FG012":"0","FG013":"0","FG014":"0","FG015":"0","FG016":"0","FG017":"1","FG018":"0","FG019":"0","FG020":"0","FG021":"0","FG022":"0","FG023":"0","FG024":"0","FG025":"0","FG026":"2","FG027":"0","FG028":"0","FG029":"0","FG030":"0","FG031":"0","FG032":"0","FG033":"0","FG034":"0","FG035":"0"}},{"type":"Physician Decision","counts":{"FG000":"1","FG001":"1","FG002":"0","FG003":"3","FG004":"0","FG005":"0","FG006":"1","FG007":"1","FG008":"0","FG009":"0","FG010":"0","FG011":"5","FG012":"0","FG013":"0","FG014":"0","FG015":"0","FG016":"0","FG017":"0","FG018":"0","FG019":"0","FG020":"0","FG021":"0","FG022":"0","FG023":"0","FG024":"0","FG025":"0","FG026":"0","FG027":"0","FG028":"0","FG029":"0","FG030":"0","FG031":"0","FG032":"0","FG033":"0","FG034":"0","FG035":"0"}},{"type":"Withdrawal by Subject","counts":{"FG000":"26","FG001":"62","FG002":"14","FG003":"16","FG004":"1","FG005":"2","FG006":"9","FG007":"5","FG008":"3","FG009":"15","FG010":"11","FG011":"7","FG012":"2","FG013":"0","FG014":"1","FG015":"11","FG016":"2","FG017":"5","FG018":"0","FG019":"0","FG020":"1","FG021":"0","FG022":"0","FG023":"0","FG024":"5","FG025":"1","FG026":"5","FG027":"1","FG028":"4","FG029":"2","FG030":"0","FG031":"0","FG032":"0","FG033":"0","FG034":"0","FG035":"0"}},{"type":"Refused further study procedures","counts":{"FG000":"0","FG001":"0","FG002":"0","FG003":"0","FG004":"0","FG005":"0","FG006":"1","FG007":"0","FG008":"0","FG009":"0","FG010":"0","FG011":"2","FG012":"0","FG013":"0","FG014":"0","FG015":"0","FG016":"0","FG017":"0","FG018":"0","FG019":"0","FG020":"0","FG021":"0","FG022":"0","FG023":"0","FG024":"0","FG025":"0","FG026":"0","FG027":"0","FG028":"0","FG029":"0","FG030":"0","FG031":"0","FG032":"0","FG033":"0","FG034":"0","FG035":"0"}},{"type":"Participants entered open label period","counts":{"FG000":"4544","FG001":"4906","FG002":"0","FG003":"0","FG004":"0","FG005":"0","FG006":"0","FG007":"0","FG008":"0","FG009":"0","FG010":"0","FG011":"0","FG012":"0","FG013":"0","FG014":"0","FG015":"0","FG016":"0","FG017":"0","FG018":"0","FG019":"0","FG020":"0","FG021":"0","FG022":"0","FG023":"0","FG024":"0","FG025":"0","FG026":"0","FG027":"0","FG028":"0","FG029":"0","FG030":"0","FG031":"0","FG032":"0","FG033":"0","FG034":"0","FG035":"0"}},{"type":"Withdrawal by parent/guardian","counts":{"FG000":"0","FG001":"0","FG002":"1","FG003":"1","FG004":"0","FG005":"1","FG006":"0","FG007":"0","FG008":"0","FG009":"0","FG010":"0","FG011":"0","FG012":"0","FG013":"0","FG014":"0","FG015":"0","FG016":"0","FG017":"0","FG018":"0","FG019":"0","FG020":"0","FG021":"0","FG022":"0","FG023":"0","FG024":"0","FG025":"0","FG026":"0","FG027":"0","FG028":"0","FG029":"0","FG030":"0","FG031":"0","FG032":"0","FG033":"0","FG034":"0","FG035":"0"}},{"type":"Medication error","counts":{"FG000":"0","FG001":"0","FG002":"0","FG003":"0","FG004":"0","FG005":"0","FG006":"0","FG007":"0","FG008":"0","FG009":"0","FG010":"2","FG011":"0","FG012":"0","FG013":"0","FG014":"0","FG015":"0","FG016":"0","FG017":"0","FG018":"0","FG019":"0","FG020":"0","FG021":"0","FG022":"0","FG023":"0","FG024":"0","FG025":"0","FG026":"0","FG027":"0","FG028":"4","FG029":"0","FG030":"0","FG031":"0","FG032":"0","FG033":"0","FG034":"0","FG035":"0"}}]},{"title":"Open-Label Period","milestones":[{"type":"STARTED","counts":{"FG000":"4544","FG001":"4906","FG002":"0","FG003":"0","FG004":"0","FG005":"0","FG006":"0","FG007":"0","FG008":"0","FG009":"0","FG010":"0","FG011":"0","FG012":"0","FG013":"0","FG014":"0","FG015":"0","FG016":"0","FG017":"0","FG018":"0","FG019":"0","FG020":"0","FG021":"0","FG022":"0","FG023":"0","FG024":"0","FG025":"0","FG026":"0","FG027":"0","FG028":"0","FG029":"0","FG030":"0","FG031":"0","FG032":"0","FG033":"0","FG034":"0","FG035":"0"}},{"type":"Received Open-label BNT162b2 30 mcg","counts":{"FG000":"4544","FG001":"4430","FG002":"0","FG003":"0","FG004":"0","FG005":"0","FG006":"0","FG007":"0","FG008":"0","FG009":"0","FG010":"0","FG011":"0","FG012":"0","FG013":"0","FG014":"0","FG015":"0","FG016":"0","FG017":"0","FG018":"0","FG019":"0","FG020":"0","FG021":"0","FG022":"0","FG023":"0","FG024":"0","FG025":"0","FG026":"0","FG027":"0","FG028":"0","FG029":"0","FG030":"0","FG031":"0","FG032":"0","FG033":"0","FG034":"0","FG035":"0"}},{"type":"COMPLETED","counts":{"FG000":"3272","FG001":"3878","FG002":"0","FG003":"0","FG004":"0","FG005":"0","FG006":"0","FG007":"0","FG008":"0","FG009":"0","FG010":"0","FG011":"0","FG012":"0","FG013":"0","FG014":"0","FG015":"0","FG016":"0","FG017":"0","FG018":"0","FG019":"0","FG020":"0","FG021":"0","FG022":"0","FG023":"0","FG024":"0","FG025":"0","FG026":"0","FG027":"0","FG028":"0","FG029":"0","FG030":"0","FG031":"0","FG032":"0","FG033":"0","FG034":"0","FG035":"0"}},{"type":"NOT COMPLETED","counts":{"FG000":"1272","FG001":"1028","FG002":"0","FG003":"0","FG004":"0","FG005":"0","FG006":"0","FG007":"0","FG008":"0","FG009":"0","FG010":"0","FG011":"0","FG012":"0","FG013":"0","FG014":"0","FG015":"0","FG016":"0","FG017":"0","FG018":"0","FG019":"0","FG020":"0","FG021":"0","FG022":"0","FG023":"0","FG024":"0","FG025":"0","FG026":"0","FG027":"0","FG028":"0","FG029":"0","FG030":"0","FG031":"0","FG032":"0","FG033":"0","FG034":"0","FG035":"0"}}],"dropWithdraws":[{"type":"Lost to Follow-up","counts":{"FG000":"109","FG001":"41","FG002":"0","FG003":"0","FG004":"0","FG005":"0","FG006":"0","FG007":"0","FG008":"0","FG009":"0","FG010":"0","FG011":"0","FG012":"0","FG013":"0","FG014":"0","FG015":"0","FG016":"0","FG017":"0","FG018":"0","FG019":"0","FG020":"0","FG021":"0","FG022":"0","FG023":"0","FG024":"0","FG025":"0","FG026":"0","FG027":"0","FG028":"0","FG029":"0","FG030":"0","FG031":"0","FG032":"0","FG033":"0","FG034":"0","FG035":"0"}},{"type":"Protocol Violation","counts":{"FG000":"377","FG001":"48","FG002":"0","FG003":"0","FG004":"0","FG005":"0","FG006":"0","FG007":"0","FG008":"0","FG009":"0","FG010":"0","FG011":"0","FG012":"0","FG013":"0","FG014":"0","FG015":"0","FG016":"0","FG017":"0","FG018":"0","FG019":"0","FG020":"0","FG021":"0","FG022":"0","FG023":"0","FG024":"0","FG025":"0","FG026":"0","FG027":"0","FG028":"0","FG029":"0","FG030":"0","FG031":"0","FG032":"0","FG033":"0","FG034":"0","FG035":"0"}},{"type":"Death","counts":{"FG000":"5","FG001":"5","FG002":"0","FG003":"0","FG004":"0","FG005":"0","FG006":"0","FG007":"0","FG008":"0","FG009":"0","FG010":"0","FG011":"0","FG012":"0","FG013":"0","FG014":"0","FG015":"0","FG016":"0","FG017":"0","FG018":"0","FG019":"0","FG020":"0","FG021":"0","FG022":"0","FG023":"0","FG024":"0","FG025":"0","FG026":"0","FG027":"0","FG028":"0","FG029":"0","FG030":"0","FG031":"0","FG032":"0","FG033":"0","FG034":"0","FG035":"0"}},{"type":"No longer meets eligibility criteria","counts":{"FG000":"20","FG001":"4","FG002":"0","FG003":"0","FG004":"0","FG005":"0","FG006":"0","FG007":"0","FG008":"0","FG009":"0","FG010":"0","FG011":"0","FG012":"0","FG013":"0","FG014":"0","FG015":"0","FG016":"0","FG017":"0","FG018":"0","FG019":"0","FG020":"0","FG021":"0","FG022":"0","FG023":"0","FG024":"0","FG025":"0","FG026":"0","FG027":"0","FG028":"0","FG029":"0","FG030":"0","FG031":"0","FG032":"0","FG033":"0","FG034":"0","FG035":"0"}},{"type":"Other","counts":{"FG000":"621","FG001":"429","FG002":"0","FG003":"0","FG004":"0","FG005":"0","FG006":"0","FG007":"0","FG008":"0","FG009":"0","FG010":"0","FG011":"0","FG012":"0","FG013":"0","FG014":"0","FG015":"0","FG016":"0","FG017":"0","FG018":"0","FG019":"0","FG020":"0","FG021":"0","FG022":"0","FG023":"0","FG024":"0","FG025":"0","FG026":"0","FG027":"0","FG028":"0","FG029":"0","FG030":"0","FG031":"0","FG032":"0","FG033":"0","FG034":"0","FG035":"0"}},{"type":"Physician Decision","counts":{"FG000":"2","FG001":"0","FG002":"0","FG003":"0","FG004":"0","FG005":"0","FG006":"0","FG007":"0","FG008":"0","FG009":"0","FG010":"0","FG011":"0","FG012":"0","FG013":"0","FG014":"0","FG015":"0","FG016":"0","FG017":"0","FG018":"0","FG019":"0","FG020":"0","FG021":"0","FG022":"0","FG023":"0","FG024":"0","FG025":"0","FG026":"0","FG027":"0","FG028":"0","FG029":"0","FG030":"0","FG031":"0","FG032":"0","FG033":"0","FG034":"0","FG035":"0"}},{"type":"Withdrawal by Subject","counts":{"FG000":"135","FG001":"25","FG002":"0","FG003":"0","FG004":"0","FG005":"0","FG006":"0","FG007":"0","FG008":"0","FG009":"0","FG010":"0","FG011":"0","FG012":"0","FG013":"0","FG014":"0","FG015":"0","FG016":"0","FG017":"0","FG018":"0","FG019":"0","FG020":"0","FG021":"0","FG022":"0","FG023":"0","FG024":"0","FG025":"0","FG026":"0","FG027":"0","FG028":"0","FG029":"0","FG030":"0","FG031":"0","FG032":"0","FG033":"0","FG034":"0","FG035":"0"}},{"type":"Refused further study procedures","counts":{"FG000":"1","FG001":"0","FG002":"0","FG003":"0","FG004":"0","FG005":"0","FG006":"0","FG007":"0","FG008":"0","FG009":"0","FG010":"0","FG011":"0","FG012":"0","FG013":"0","FG014":"0","FG015":"0","FG016":"0","FG017":"0","FG018":"0","FG019":"0","FG020":"0","FG021":"0","FG022":"0","FG023":"0","FG024":"0","FG025":"0","FG026":"0","FG027":"0","FG028":"0","FG029":"0","FG030":"0","FG031":"0","FG032":"0","FG033":"0","FG034":"0","FG035":"0"}},{"type":"Adverse Event","counts":{"FG000":"1","FG001":"0","FG002":"0","FG003":"0","FG004":"0","FG005":"0","FG006":"0","FG007":"0","FG008":"0","FG009":"0","FG010":"0","FG011":"0","FG012":"0","FG013":"0","FG014":"0","FG015":"0","FG016":"0","FG017":"0","FG018":"0","FG019":"0","FG020":"0","FG021":"0","FG022":"0","FG023":"0","FG024":"0","FG025":"0","FG026":"0","FG027":"0","FG028":"0","FG029":"0","FG030":"0","FG031":"0","FG032":"0","FG033":"0","FG034":"0","FG035":"0"}},{"type":"Withdrawal by parent/guardian","counts":{"FG000":"1","FG001":"0","FG002":"0","FG003":"0","FG004":"0","FG005":"0","FG006":"0","FG007":"0","FG008":"0","FG009":"0","FG010":"0","FG011":"0","FG012":"0","FG013":"0","FG014":"0","FG015":"0","FG016":"0","FG017":"0","FG018":"0","FG019":"0","FG020":"0","FG021":"0","FG022":"0","FG023":"0","FG024":"0","FG025":"0","FG026":"0","FG027":"0","FG028":"0","FG029":"0","FG030":"0","FG031":"0","FG032":"0","FG033":"0","FG034":"0","FG035":"0"}},{"type":"Did not receive Open-label BNT162b2 30 mcg","counts":{"FG000":"0","FG001":"476","FG002":"0","FG003":"0","FG004":"0","FG005":"0","FG006":"0","FG007":"0","FG008":"0","FG009":"0","FG010":"0","FG011":"0","FG012":"0","FG013":"0","FG014":"0","FG015":"0","FG016":"0","FG017":"0","FG018":"0","FG019":"0","FG020":"0","FG021":"0","FG022":"0","FG023":"0","FG024":"0","FG025":"0","FG026":"0","FG027":"0","FG028":"0","FG029":"0","FG030":"0","FG031":"0","FG032":"0","FG033":"0","FG034":"0","FG035":"0"}}]}],"recruitment":"This study was conducted in 6 parts: sub-study A (SSA), sub-study B (SSB), sub-study C (SSC), sub-study D (SSD), sub-study E (SSE) and sub-study F (SSF).","preAssignment":"SSA: 10133 participants randomized, 10121 vaccinated and evaluated. SSB: 1487 participants randomized,1485 vaccinated and evaluated. SSC: 140 participants randomized, vaccinated, evaluated. SSD: 1469 participants randomized 1467 vaccinated, 1465vaccinated with 30 mcg BNT162b2 and BNT162b2 OMI and evaluated. SSE: 3020 participants randomized, 3014 vaccinated, 3010 vaccinated with 30 and 60 mcg BNT162b2 and BNT162b2 OMI and evaluated. SSF: 123 participants randomized,122 vaccinated and evaluated."}],"_healthCanadaChecked":true,"companionDiagnostics":[],"_genericFilersChecked":true,"structuredTrialResults":[{"hr":"95.3","nctId":"NCT04955626","phase":"PHASE3","pValue":"","ciLower":"89.5","ciUpper":"98.3","endpoint":"SSA: Occurrence of First COVID-19 Infection After Booster Dose Per 1000 Person-Years of Blinded Follow-up Without Evidence of Past SARS-CoV-2 Infection at Interim Analysis: Evaluable Efficacy Population","enrollment":16372}],"genericManufacturerList":[],"phase":"marketed","status":"approved","companyName":"Pfizer","companyId":"pfizer","modality":"mRNA-based vaccine","firstApprovalDate":"","enrichmentLevel":5,"visitCount":8,"regulatoryByCountry":[{"country_code":"AU","regulator":"TGA","status":"approved","approval_date":null,"mah":"","brand_name_local":null,"application_number":null},{"country_code":"CH","regulator":"Swissmedic","status":"approved","approval_date":null,"mah":"","brand_name_local":null,"application_number":null},{"country_code":"NO","regulator":"NoMA","status":"approved","approval_date":null,"mah":"","brand_name_local":null,"application_number":null},{"country_code":"IS","regulator":"IMA","status":"approved","approval_date":null,"mah":"","brand_name_local":null,"application_number":null},{"country_code":"NZ","regulator":"Medsafe","status":"approved","approval_date":null,"mah":"","brand_name_local":null,"application_number":null},{"country_code":"AT","regulator":"AGES","status":"approved","approval_date":null,"mah":"","brand_name_local":null,"application_number":null},{"country_code":"BE","regulator":"FAMHP","status":"approved","approval_date":null,"mah":"","brand_name_local":null,"application_number":null},{"country_code":"EU","regulator":"EMA","status":"approved","approval_date":null,"mah":"","brand_name_local":null,"application_number":""},{"country_code":"GB","regulator":"MHRA","status":"approved","approval_date":null,"mah":"","brand_name_local":null,"application_number":""},{"country_code":"BG","regulator":"BDA","status":"approved","approval_date":null,"mah":"","brand_name_local":null,"application_number":null},{"country_code":"HR","regulator":"HALMED","status":"approved","approval_date":null,"mah":"","brand_name_local":null,"application_number":null},{"country_code":"CY","regulator":"PHS","status":"approved","approval_date":null,"mah":"","brand_name_local":null,"application_number":null},{"country_code":"CZ","regulator":"SUKL","status":"approved","approval_date":null,"mah":"","brand_name_local":null,"application_number":null},{"country_code":"DK","regulator":"DKMA","status":"approved","approval_date":null,"mah":"","brand_name_local":null,"application_number":null},{"country_code":"EE","regulator":"SAM","status":"approved","approval_date":null,"mah":"","brand_name_local":null,"application_number":null},{"country_code":"FI","regulator":"Fimea","status":"approved","approval_date":null,"mah":"","brand_name_local":null,"application_number":null},{"country_code":"FR","regulator":"ANSM","status":"approved","approval_date":null,"mah":"","brand_name_local":null,"application_number":null},{"country_code":"DE","regulator":"BfArM","status":"approved","approval_date":null,"mah":"","brand_name_local":null,"application_number":null},{"country_code":"GR","regulator":"EOF","status":"approved","approval_date":null,"mah":"","brand_name_local":null,"application_number":null},{"country_code":"HU","regulator":"OGYEI","status":"approved","approval_date":null,"mah":"","brand_name_local":null,"application_number":null},{"country_code":"IE","regulator":"HPRA","status":"approved","approval_date":null,"mah":"","brand_name_local":null,"application_number":null},{"country_code":"IT","regulator":"AIFA","status":"approved","approval_date":null,"mah":"","brand_name_local":null,"application_number":null},{"country_code":"LV","regulator":"ZVA","status":"approved","approval_date":null,"mah":"","brand_name_local":null,"application_number":null},{"country_code":"LT","regulator":"VVKT","status":"approved","approval_date":null,"mah":"","brand_name_local":null,"application_number":null},{"country_code":"LU","regulator":"MS","status":"approved","approval_date":null,"mah":"","brand_name_local":null,"application_number":null},{"country_code":"MT","regulator":"MMA","status":"approved","approval_date":null,"mah":"","brand_name_local":null,"application_number":null},{"country_code":"NL","regulator":"MEB","status":"approved","approval_date":null,"mah":"","brand_name_local":null,"application_number":null},{"country_code":"PL","regulator":"URPL","status":"approved","approval_date":null,"mah":"","brand_name_local":null,"application_number":null},{"country_code":"PT","regulator":"Infarmed","status":"approved","approval_date":null,"mah":"","brand_name_local":null,"application_number":null},{"country_code":"RO","regulator":"ANMDMR","status":"approved","approval_date":null,"mah":"","brand_name_local":null,"application_number":null},{"country_code":"SK","regulator":"SIDC","status":"approved","approval_date":null,"mah":"","brand_name_local":null,"application_number":null},{"country_code":"SI","regulator":"JAZMP","status":"approved","approval_date":null,"mah":"","brand_name_local":null,"application_number":null},{"country_code":"ES","regulator":"AEMPS","status":"approved","approval_date":null,"mah":"","brand_name_local":null,"application_number":null},{"country_code":"SE","regulator":"MPA","status":"approved","approval_date":null,"mah":"","brand_name_local":null,"application_number":null},{"country_code":"BR","regulator":"ANVISA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"MX","regulator":"COFEPRIS","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AR","regulator":"ANMAT","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"TR","regulator":"TITCK","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"IN","regulator":"CDSCO","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"TH","regulator":"FDA-TH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"MY","regulator":"NPRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"PH","regulator":"FDA-PH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"CO","regulator":"INVIMA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"ZA","regulator":"SAHPRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"TW","regulator":"TFDA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"HK","regulator":"DH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"pricingByCountry":[{"country_code":"US","currency":"USD","price_amount":"80000.00","price_per":"year","price_type":"annual_list","annual_cost_usd":null,"reimbursement_status":null}],"trialStats":{"total":1,"withResults":1},"validation":{"fieldsValidated":4,"lastValidatedAt":"2026-04-20T08:33:42.246013+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}